We are live on ! Find out more
AI

Analytic Investors Portfolio holdings

AUM $8.93B
1-Year Est. Return 13.54%
This Fund
S&P 500
This Quarter Est. Return
+2.95%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.14%
5 Year Est. Return
10 Year Est. Return
AUM
$6.22B
AUM Growth
+$186M
Cap. Flow
+$50.9M
Cap. Flow %
0.82%
Top 10 Hldgs %
20.46%
Holding
730
New
167
Increased
166
Reduced
151
Closed
229

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$125M
2
PEP icon
PepsiCo
PEP
+$64.4M
3
USB icon
US Bancorp
USB
+$59.8M
4
TSN icon
Tyson Foods
TSN
+$49.4M
5
TGT icon
Target
TGT
+$48.9M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$106M
2
APTV icon
Aptiv
APTV
+$34.7M
3
AGNC icon
AGNC Investment
AGNC
+$34.2M
4
NEM icon
Newmont
NEM
+$33.9M
5
GEN icon
Gen Digital
GEN
+$28.3M

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.78%
2 Healthcare 13.79%
3 Financials 11.85%
4 Utilities 10.97%
5 Technology 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSC
76
DELISTED
Computer Sciences
CSC
$24.5M 0.39%
1,124,017
-391,367
-26% -$8.23M
NOC icon
77
Northrop Grumman
NOC
$77.7B
$24.4M 0.39%
256,228
+122,268
+91% +$11.3M
LUMN icon
78
Lumen
LUMN
$6.4B
$24.4M 0.39%
777,442
+112,800
+17% +$3.84M
CBRE icon
79
CBRE Group
CBRE
$41.8B
$24.3M 0.39%
1,048,442
+784,706
+298% +$18.2M
MMM icon
80
3M
MMM
$91.2B
$23.7M 0.38%
237,571
-29,443
-11% -$2.86M
EMR icon
81
Emerson Electric
EMR
$82.5B
$23.7M 0.38%
366,300
-8,216
-2% -$502K
XEL icon
82
Xcel Energy
XEL
$50.7B
$22.2M 0.36%
804,939
+69,169
+9% +$1.98M
MPC icon
83
Marathon Petroleum
MPC
$90B
$21.9M 0.35%
679,854
+204,032
+43% +$7.18M
MON
84
DELISTED
Monsanto Co
MON
$21.8M 0.35%
209,141
+82,588
+65% +$8.3M
CAG icon
85
Conagra Brands
CAG
$7.25B
$21.7M 0.35%
920,940
-120,125
-12% -$3.24M
STRZA
86
DELISTED
Starz - Series A
STRZA
$21.6M 0.35%
768,491
+297,330
+63% +$7.33M
PNW icon
87
Pinnacle West Capital
PNW
$12.8B
$21.4M 0.34%
390,431
-233,272
-37% -$13.1M
MKC icon
88
McCormick & Company Non-Voting
MKC
$13.7B
$21.1M 0.34%
653,736
+57,936
+10% +$2.03M
M icon
89
Macy's
M
$6.48B
$20.8M 0.33%
480,290
+67,388
+16% +$3.15M
PBI icon
90
Pitney Bowes
PBI
$2.46B
$20.7M 0.33%
1,137,884
-741,455
-39% -$12.2M
CL icon
91
Colgate-Palmolive
CL
$73.6B
$20.5M 0.33%
344,984
-180,736
-34% -$10.7M
MRK icon
92
Merck
MRK
$326B
$20.2M 0.33%
444,593
+370,454
+500% +$16.9M
VVC
93
DELISTED
Vectren Corporation
VVC
$20.2M 0.32%
604,235
+100,256
+20% +$3.45M
MU icon
94
Micron Technology
MU
$983B
$19.9M 0.32%
+1,136,657
New +$16.5M
JPM icon
95
JPMorgan Chase
JPM
$942B
$19.7M 0.32%
381,294
+374,606
+5,601% +$20.1M
STX icon
96
Seagate
STX
$180B
$19.7M 0.32%
449,640
+65,379
+17% +$2.75M
FDS icon
97
Factset
FDS
$9.57B
$18.9M 0.3%
+172,836
New +$18.7M
BPOP icon
98
Popular Inc
BPOP
$11B
$18.6M 0.3%
706,899
+435,135
+160% +$13.7M
MNST icon
99
Monster Beverage
MNST
$93.2B
$18.5M 0.3%
2,340,444
+328,200
+16% +$3.24M
RHI icon
100
Robert Half
RHI
$3.98B
$18.5M 0.3%
+474,265
New +$17.5M

Similar funds

Analytic Investors's Q3 2013 Portfolio in Review

As of Q3 2013, Analytic Investors held 730 positions worth $6.22B, up 3.1% from $6.03B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Analytic Investors's Q3 2013 filing shows 167 new, 166 increased, 151 reduced and 229 closed positions. Its largest new stake was T. Rowe Price: 421,030 shares worth $30.3M. The largest sale was Amgen, an estimated $106M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Analytic Investors's largest Q3 2013 buy was T. Rowe Price: 421,030 shares worth $30.3M.
  • Analytic Investors added most to AT&T in Q3 2013, an estimated $125M increase.
  • Analytic Investors's biggest Q3 2013 reduction was Amgen, cutting an estimated $106M.
  • Analytic Investors fully exited Aptiv in Q3 2013, selling an estimated $34.7M.
  • Analytic Investors's ten largest holdings make up 20% of its $6.22B portfolio in Q3 2013.
  • Analytic Investors opened 167 new positions and closed 229 in Q3 2013.
  • Analytic Investors's portfolio value rose 3.1% quarter-over-quarter to $6.22B.

Based on Analytic Investors's 13F filing for Q3 2013, filed 12 Nov 2013.